Several stocks are likely to attract investors’ attention in the stock market today following regulatory developments, major order wins and quarterly earnings announcements. Lupin will be watched after an inspection by the US Food and Drug Administration (USFDA) resulted in one observation, while KEC International and B L Kashyap have announced significant new orders.
Investors will also track developments involving Sahajanand Medical Technologies and Tonbo Imaging, along with the quarterly results of several major companies. Here are the key stocks and announcements to watch.
Q2FY27 Results: Companies Announcing Quarterly Earnings Today
A number of listed companies are scheduled to announce their financial results for the second quarter of FY27. These include Tata Consumer Products, One 97 Communications (Paytm), Mankind Pharma, Ather Energy, Dalmia Bharat, Bank of Maharashtra, Indian Overseas Bank, Sona BLW Precision Forgings, Supreme Industries and KFin Technologies.
Other companies on the results calendar include ITC Hotels, Aditya Birla Real Estate, Aegis Logistics, Avantel, DCM Shriram, Dhanlaxmi Bank, Everest Industries, Aegis Vopak Terminals, Aequs and Nazara Technologies.
The announced results could provide investors with updates on revenue, profitability and business performance across multiple sectors.
Lupin, KEC International and BL Kashyap in Focus
Lupin: Shares of pharmaceutical company Lupin will be in focus after the USFDA inspected its manufacturing facility in Goa from October 19 to October 23. The inspection concluded with one observation, and the regulator issued a Form 483. Investors will monitor further information about the observation and the company’s proposed corrective actions.
KEC International: The engineering and construction company has secured a turnkey order worth ₹2,872 crore from Power Grid Corporation of India. The contract falls under its transmission and distribution business and involves the design, supply and installation of 765 kV transmission lines.
B L Kashyap and Sons: The company has received a ₹495.86 crore order from Signature Global India. The project involves civil construction work for four towers and a basement, along with partial mechanical, electrical and plumbing (MEP) work. The new contract is an important development for the company’s order book.
Infosys, Kotak Bank and Other Stocks in Focus
Infosys: The company has projected constant-currency revenue growth of 1% to 2% and an operating margin of 20% to 22% for FY27. During the July–September quarter, Infosys reported a profit after tax (PAT) of ₹7,823 crore, an increase of 6% year-on-year. Revenue from operations rose 11% to ₹49,244 crore.
Kotak Mahindra Bank: The bank reported a 29.5% year-on-year increase in standalone net profit to ₹4,212 crore.
IndusInd Bank: The lender posted a profit of ₹1,176.1 crore, compared with a loss of ₹444.8 crore in the corresponding quarter of the previous year.
Coforge: The IT services company recorded a 56.5% increase in profit to ₹588.1 crore, while revenue climbed 53.6% to ₹6,170.8 crore.
Dr Reddy’s Laboratories: The pharmaceutical company’s profit declined 36% to ₹913.4 crore.
Investors will assess these financial figures alongside other company-specific developments when evaluating the stocks.
F&O Ban List: Ambuja Cements, Kaynes Technology and SAIL
Shares of Ambuja Cements, Kaynes Technology India and Steel Authority of India (SAIL) remain on the futures and options (F&O) ban list.
Market participants should review the applicable exchange rules and the latest company disclosures before placing trades. Stock prices can move in response to earnings, regulatory updates, order announcements and broader market conditions.
Disclaimer
This article is for informational and educational purposes only and should not be considered investment advice or a recommendation to buy or sell any security. Stock market conditions, company announcements and exchange restrictions may change. Investors should verify the latest disclosures through official stock exchange filings and consult a qualified financial adviser before making investment decisions. All investments in securities involve market risks.